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According to the literature available, very few cases of pancreatitis in association multiple myeloma have been reported [1-5]. The most common cause 
being hypercalcemia induced pancreatitis and incidence of 
hypercalcemia is about (30%) in cases of multiple myeloma. 
Others causes include drug-induced pancreatitis and direct 
invasion by malignant cells.
CASE REPORT
A 68-year-old male presented to our hospital with complaints of pain 
abdomen, nausea, and vomiting for 10 days. He also had a history 
of low backache for the past 3 months and easy fatigability, and 
progressive weight loss of approximately 15 kg in the past 1 year. 
In the past, patient drank alcohol occasionally and stopped 5 years 
ago. On general physical examination, the patient was emaciated 
(body mass index - 16.8 kg/m2), and pallor was present. On per 
abdominal examination, tenderness was present in the epigastric 
region, flanks were full and shifting dullness was present.
His routine laboratory investigations revealed hemoglobin 
of 7.2 g/dl, total leukocytes count 9200/mm3, platelet count of 
1,08,000/ml blood urea of 84 mg/dl and serum creatinine of 
3.7 mg/dl. Erythrocyte sedimentation rate was 112 mm at the end 
of 1st h, and peripheral smear examination showed microcytic, 
hypochromic picture with mild anisocytosis and poikilocytosis. 
Blood and urine cultures were sterile. His total serum protein 
was 13.82 g/dl with serum albumin of 2.26 g/dl, serum globulin 
of 11.56 g/dl, and A: G ratio of 0.20. His serum calcium was 
6.7 mg/dl, and serum triglyceride level was 67.8 mg/dl. His blood 
sugar, liver enzymes, and bilirubin were all within the normal 
ranges. Viral markers including HBsAg, anti-hepatitis C virus, 
and human immunodeficiency virus were also non-reactive. He 
had elevated levels of serum amylase (1954 U/L, normal: 23-88 
U/L) and serum lipase (217.7 U/L, normal: <60 U/L).
Ultrasonography abdomen and kidney ureter bladder (KUB) 
showed altered echotexture of normal sized pancreas suggesting 
acute pancreatitis. Contrast enhanced computed tomography 
(CECT) of abdomen showed evidence of bulky tail of pancreas 
with evidence of multiple hypodense ill-defined lesions in 
body and tail of pancreas suggestive of necrosis (<30%). There 
were peripancreatic fluid and necrosis with evidence of diffuse 
mesenteric fat stranding and moderate ascites. Common bile 
duct and gall bladder were normal. On the basis of these features, 
diagnosis of acute necrotizing pancreatitis was made with 
modified CT severity index score of 8 (pancreatic inflammation: 
4 points, pancreatic necrosis <30%: 2 points, and extrapancreatic 
complications: 2 points). The patient was managed conservatively, 
with parenteral nutrition, and intravenous fluids and was 
maintained nil orally till pain abdomen subsided with supportive 
therapy, his renal functions improved.
His X-ray lumbosacral spine showed generalized osteoporotic 
changes with collapse of L3 vertebra. X-ray skull and pelvis also showed 
osteoporotic changes. His urine examination was negative for bence 
jones proteins. Serum electrophoresis showed: Total protein - 9.2 g/dl, 
albumin - 1.55 g/dl, α1 proteins - 0.24 g (normal), α2 globulin - 0.49 g 
(low), β globulin - 0.40 g (low), γ globulin - 6.53 g (high), and M 
spike were detected: 5.88 g/dl. However, immunoelectrophoresis and 
flow cytometry could not be performed due to its unavailability in 
our setup and cost constraints. Bone marrow biopsy showed plasma 
cell infiltration (30% plasma cells) suggestive of multiple myeloma. 
Patient satisfied the diagnostic criteria of multiple myeloma [1], and 
chemotherapy was planned; hence, was being referred to higher 
oncological center. Despite the best efforts patient succumbed to his 
illness and the chemotherapy could not be initiated (Fig. 1).
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DISCUSSION
Our patient presented with a clinical picture of acute pancreatitis 
of 10 days duration. On further evaluation, he was diagnosed to 
have concurrent multiple myeloma. This presentation was similar 
to the cases reported in literature previously, where pancreatitis 
was the first clinical manifestation, and later on multiple myeloma 
was detected. Pancreatitis has been rarely reported in association 
with multiple myeloma, and in most of the cases, the cited reason 
was hypercalcemia [2,3], initiation of chemotherapy [4,5], or direct 
infiltration of pancreas by plasma cells [6,7]. Multiple myeloma is 
usually associated with hypercalcemia and incidence of hypercalcemia 
is about 30% in cases of multiple myeloma [8]. However, our patient’s 
serum calcium and triglyceride were within the normal range, so 
hypercalcemia induced pancreatitis was ruled out.
Several drugs can cause pancreatitis, and the common drugs 
are azathioprine, 6-mercaptopurine, sulfonamides, tetracyclines, 
valproic acid, and 5-aminosalicylic acid [1]. In cases with multiple 
myeloma, the drugs which were reported to cause pancreatitis 
are bortezomib and vincristine, doxorubicin and dexamethasone 
combination chemotherapy [4,5]. Bortezomib is a selective and 
reversible proteasome inhibitor, which is used for the treatment 
of multiple myeloma. Our patient was a reformed alcoholic 
and stopped drinking 5 years back, so possibility of alcoholic 
pancreatitis was ruled out. Detailed drug history of the patient 
was taken, he denied taking any medications in the past and was 
never given any chemotherapeutic drug for multiple myeloma. 
Thus, the possibility of drug-induced pancreatitis was unlikely in 
our case. Ultrasound and CECT abdomen also did not reveal any 
lesion or obstruction in common bile duct and gall bladder.
Multiple myeloma is a disease characterized by malignant 
proliferation of plasma cells. Although it typically involves 
medullary bones, extramedullary presentation also occurs in about 
3-4% of cases, more common in males [6]. Extramedullary spread 
of multiple myeloma can occur in two ways that are either direct 
extension from skeletal tumor or hematogenous metastatic spread 
and is associated with poor prognosis [9,10]. 80-90% of these 
extramedullary tumors usually develop in head and neck area, but 
gastrointestinal involvement is seen in about 10% of cases, wherein 
2.3% of the cases had pancreatic involvement as per autopsy 
reports. The most cases of plasma cell infiltration are microscopic 
with very few presenting with well-defined masses [6]. Endoscopic 
ultrasound guided - fine needle aspiration cytology (EUS-FNAC) 
is one of the best modalities to diagnose such cases. In our case, 
CECT abdomen showed evidence of ill-defined hypoechoic lesions 
in the body and tail of pancreas; therefore, possibility of direct 
invasion of pancreas by plasma cells can be suspected. However, 
confirmation could not be done due to lack of availability/expertise 
of EUS-FNAC and CT guided biopsy in our setup.
Renal failure is seen in almost 25% of the cases of multiple 
myeloma; although the most common cause of renal involvement 
in such cases is hypercalcemia, others being glomerular deposits, 
recurrent infections and use of nephrotoxic drugs. Prerenal 
azotemia with raised blood urea nitrogen levels has also been 
reported with acute pancreatitis, resulting from loss of plasma 
into retroperitoneal space and peritoneal cavity [1]. Therefore, 
renal impairment in our case could have been multifactorial.
CONCLUSION
This case highlights the myriad of clinical manifestations that can be 
associated with multiple myeloma. It is essential to evaluate a patient 
with multiple myeloma for other extramedullary manifestation as 
they are associated with poor prognosis and outcomes.
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